Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzhemer's disease

Chinese Medical Sciences Journal

Volumn 20, Issue 4, 2005, Pages 247-251

  Zhang, Ying Dong ^a   Ke, Xiao Yan ^a   Shen, Wei ^a   Liu, Yang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cystathionine synthase; Homocysteine; N5, N10 methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; CYTOSINE; HOMOCYSTEINE; THYMINE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CAPILLARY ELECTROPHORESIS; CBS GENE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYSTATHIONINE BETA-SYNTHASE; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 30444457210     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 10-methylenetetrahydrofolate reductase gene polymorphism with cerebral infarction. Chin Med Sci J 2002;17: 247-51.
2. McIlroy SP, Dynan KB, Lawson JT, et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002;33:2351-6.
3. Zhang YD, Zhu ZG, Liu Y. The determination of plasma homocysteine level and its relation to cerebral infarction. Chin J Clin Neurosci 2002;10:130-2.
4. Tsai MY, Bignell M, Schwichtenberg K, et al. High prevalence of a mutation in the cystathionine beta-synthase gene. Am J Hum Genet 1996;59:1262-7.
5. 12 and folate in vascular dementia and in Alzheimer disease. Clin Chem Lab Med 2004;42:1032-5.
6. Joosten E, Lesaffre E, Riezler R, et al. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol A Biol Sci Med Sci 1997;52: M76-9.
7. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
8. Loscalzo J. Homocysteine and dementias. New Eng J Med 2002; 346:466-8.
9. Shi J, Perry G, Smith MA, et al. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000; 21:357-61.
10. 12, and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 2001;47:324-9.
11. Wakutani Y, Kowa H, Kusumi M, et al. The regulatory region polymorphism of the MTHFR gene are not associated with Alzheimer's disease. Dement Geriatr Cogn Disord 2004;17:147-50.
12. Dilley A, Hooper WC, El-Jamil M, et al. Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C→ T677) and cystathione beta-synthase (CBS G→A919, CBS T→ C833) are not associated with myocardial infarction in African Americans. Thromb Res 2001;103:109-15.
13. Zhang GS, Dai CW, Correlation analysis between plasma homocysteine level and polymorphism of homocysteine metabolism related enzymes in ischemic cerebrovascular or cardiovascular diseases. Chin J Hematol 2002;23:126-9.